Upadacitinib Shows Strong Scalp Regrowth in Severe Alopecia Areata Trials
Upadacitinib achieved significant scalp hair regrowth, with roughly half of severe alopecia areata patients reaching 80 percent or more scalp coverage at week 24 across two phase 3 clinical trials. … Read More